PIN35 COST-EFFECTIVENESS ANALYSIS OF PALIVIZUMAB FOR RESPIRATORY SYNCYTIAL VIRUS INFECTION IN HIGH-RISK INFANTS IN JAPAN

Cost Effectiveness ◽

High Risk ◽

Virus Infection ◽

Effectiveness Analysis ◽

Syncytial Virus ◽

Palivizumab for Infants < 29 Weeks in Hong Kong without a Clear-Cut Season for Respiratory Syncytial Virus Infection—A Cost-Effectiveness Analysis

Journal of Tropical Pediatrics ◽

10.1093/tropej/fmx086 ◽

2017 ◽

Vol 64 (5) ◽

pp. 418-425 ◽

Cited By ~ 2

Author(s):

Shing-Yan Robert Lee ◽

Ka Li Kwok ◽

Daniel Kwok Keung Ng ◽

Kam Lun Hon

Keyword(s):

Hong Kong ◽

Cost Effectiveness ◽

Virus Infection ◽

Clear Cut ◽

Effectiveness Analysis ◽

Syncytial Virus

Palivizumab for respiratory syncytial virus prophylaxis in high-risk infants: a cost-effectiveness analysis

Clinical Therapeutics ◽

10.1016/s0149-2918(00)83032-5 ◽

2000 ◽

Vol 22 (11) ◽

pp. 1357-1369 ◽

Cited By ~ 38

Author(s):

Jennifer H. Lofland ◽

Suzanne M. Touch ◽

John P. O'Connor ◽

Mary Lou Chatterton ◽

Elizabeth D. Moxey ◽

...

Keyword(s):

Cost Effectiveness ◽

High Risk ◽

Effectiveness Analysis ◽

Syncytial Virus ◽

Cost-Effectiveness Analysis of Palivizumab as a Prophylaxis for Respiratory Syncytial Virus (RSV) Infection in High-Risk Late Preterm Infants in the Netherlands

Value in Health ◽

10.1016/j.jval.2013.08.286 ◽

2013 ◽

Vol 16 (7) ◽

pp. A372

Author(s):

M.K. Langenfeld ◽

S. Visser

Keyword(s):

Cost Effectiveness ◽

High Risk ◽

The Netherlands ◽

Preterm Infants ◽

Late Preterm Infants ◽

Effectiveness Analysis ◽

Rsv Infection ◽

Syncytial Virus

Respiratory syncytial virus infection in high risk infants and the potential impact of prophylaxis in a United Kingdom cohort

Archives of Disease in Childhood ◽

10.1136/adc.83.4.313 ◽

2000 ◽

Vol 83 (4) ◽

pp. 313-316 ◽

Cited By ~ 47

Author(s):

S. J Clark

Keyword(s):

United Kingdom ◽

High Risk ◽

Virus Infection ◽

Potential Impact ◽

Syncytial Virus ◽

Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk Infants

PEDIATRICS ◽

10.1542/peds.102.3.531 ◽

1998 ◽

Vol 102 (3) ◽

pp. 531-537 ◽

Cited By ~ 1251

Author(s):

Keyword(s):

Monoclonal Antibody ◽

High Risk ◽

Virus Infection ◽

Syncytial Virus ◽

Editorial - Respiratory Syncytial Virus Infection in High-Risk Infants

The Open Microbiology Journal ◽

10.2174/1874285801105010127 ◽

2011 ◽

Vol 5 (1) ◽

pp. 127-127

Author(s):

Bernhard Resch

Keyword(s):

High Risk ◽

Virus Infection ◽

Syncytial Virus ◽

Cost-effectiveness of Palivizumab for Respiratory Syncytial Virus Infection in High-risk Children, Based on Long-term Epidemiologic Data From Austria

The Pediatric Infectious Disease Journal ◽

10.1097/inf.0b013e318235455b ◽

2012 ◽

Vol 31 (1) ◽

pp. e1-e8 ◽

Cited By ~ 45

Author(s):

Bernhard Resch ◽

Constanze Sommer ◽

Mark J. C. Nuijten ◽

Susanne Seidinger ◽

Evelyn Walter ◽

...

Keyword(s):

Cost Effectiveness ◽

High Risk ◽

Virus Infection ◽

Epidemiologic Data ◽

Syncytial Virus ◽

High Risk Children

Survey of pediatric ward hospitalization due to respiratory syncytial virus infection after the introduction of palivizumab to high-risk infants in Japan

Pediatrics International ◽

10.1111/j.1442-200x.2010.03249.x ◽

2011 ◽

Vol 53 (3) ◽

pp. 368-373 ◽

Cited By ~ 8

Author(s):

Satoshi Kusuda ◽

Naoto Takahashi ◽

Takami Saitoh ◽

Masaru Terai ◽

Hisashi Kaneda ◽

...

Keyword(s):

High Risk ◽

Virus Infection ◽

Pediatric Ward ◽

Syncytial Virus ◽

Association of TLR4 Polymorphisms with Symptomatic Respiratory Syncytial Virus Infection in High-Risk Infants and Young Children

The Journal of Immunology ◽

10.4049/jimmunol.179.5.3171 ◽

2007 ◽

Vol 179 (5) ◽

pp. 3171-3177 ◽

Cited By ~ 126

Author(s):

Agnes A. Awomoyi ◽

Prasad Rallabhandi ◽

Toni I. Pollin ◽

Eva Lorenz ◽

Marcelo B. Sztein ◽

...

Keyword(s):

High Risk ◽

Virus Infection ◽

Young Children ◽

Syncytial Virus ◽

High Risk Infants ◽

Infants And Young Children

Clinical and Pharmacological Aspects of Immunoprophylaxis for Respiratory Syncytial Virus Infection in High-Risk Infants

Current Drug Metabolism ◽

10.2174/1389200211314020010 ◽

2013 ◽

Vol 14 (2) ◽

pp. 216-225

Author(s):

Marcello Lanari ◽

Michela Silvestri ◽

Giovanni A. Rossi

Keyword(s):

High Risk ◽

Virus Infection ◽

Syncytial Virus ◽